Accès ouvert
2025
article
OpenAlex
Giulia Loffreda, Reynold G. B. Senesi, Karin Diaconu, Ayesha Idriss et autres
Non-communicable diseases (NCDs) represent a rising health burden globally, yet low- and middle-income countries (LMICs), particularly fragile states, face persistent barriers to NCD prevention and control policy adoption and implementation. This qualitative case study examines the factors influencing NCD policy adoption in …
gb, pk
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Guanyang Zou, Sophie Witter, Lizzie Caperon, John Walley et autres
BACKGROUND: Sierra Leone, a fragile country, is facing an increasingly significant burden of non-communicable diseases (NCDs). Facilitated by an international partnership, a project was developed to adapt and pilot desktop guidelines and other clinical support tools to strengthen primary care-based hypertension and …
cn, gb, Sierra Leone
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Ayesha Idriss, Karin Diaconu, Guanyang Zou, Reynold G. B. Senesi et autres
Introduction: Non-communicable diseases (NCDs) are the leading cause of mortality globally. In Africa, they are expected to increase by 25% by 2030. However, very little is known about community perceptions of risk factors and factors influencing health-seeking behaviour, especially in fragile settings. …
gb, Sierra Leone, cn
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Sophie Witter, Guanyang Zou, Karin Diaconu, Reynold G. B. Senesi et autres
BACKGROUND: The growing burden of non-communicable diseases in low- and middle-income countries presents substantive challenges for health systems. This is also the case in fragile, post-conflict and post-Ebola Sierra Leone, where NCDs represent an increasingly significant disease burden (around 30% of adult …
gb, cn, Sierra Leone
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Rosalind J. Carter, Reynold G. B. Senesi, Peter Dawson, Ibrahim J. Gassama et autres
The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE), a phase 2/3 trial of an investigational Ebola vaccine, was implemented in April 2015 in Sierra Leone. Healthcare and Ebola frontline workers were randomized to immediate (within 7 days) or deferred …
us, Sierra Leone
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Leigh Ann Miller, Emily Stanger, Reynold G. B. Senesi, Nick DeLuca et autres
During May 23, 2014-January 10, 2015, Sierra Leone reported 7,777 confirmed cases of Ebola virus disease (Ebola). In response to the epidemic, on August 5, Sierra Leone's Emergency Operations Center established a toll-free, nationwide Ebola call center. The purpose of the call …